The Power List 2018 – Champions of Change
Professor of Pharmacology and Pharmacotherapy, University of Lisbon; Chair of the EMA Committee of Orphan Medicinal Products
After studying pharmacy at university and then moving into toxicology, Bruno became an assessor for the Portuguese medicine regulator INFARMED before moving to the European Medicines Agency. From there, he developed a passion for the regulation of orphan diseases, creating incentives for development and therefore improving public health. He recently received the EURORDIS Rare Disease Leadership Award. “I would like to see a better and earlier dialogue with regulators in order for drug development to be as smooth as possible. There are still several missed opportunities of interaction with regulators and we simply cannot afford that, especially in some fields such as drug development for rare diseases,” says Bruno.